According to 180 Life Sciences's latest financial reports the company's current earnings (TTM) are -$22.29 M. In 2022 the company made an earning of -$39.67 M a decrease over its 2021 earnings that were of -$20.35 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$22.29 M | -43.82% |
2022 | -$39.67 M | 94.95% |
2021 | -$20.35 M | 86.6% |
2020 | -$10.91 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 397.12% | ๐บ๐ธ USA |